The Johns Hopkins University School of Medicine Division of Clinical Pharmacology — Baltimore, Maryland

The Johns Hopkins University School of Medicine Division of Clinical Pharmacology is a clinical research site located in Baltimore, Maryland, United States 21210.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

The Johns Hopkins University School of Medicine Division of Clinical Pharmacology has participated in 1 clinical trials.

Therapeutic areas: Cytochrome P450 CYP3A5 Enzyme Polymorphism, Healthy Subjects, Pharmacokinetics of Maraviroc.

Sponsors: Johns Hopkins University.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Johns Hopkins University School of Medicine Division of Clinical Pharmacology?

The Johns Hopkins University School of Medicine Division of Clinical Pharmacology has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Johns Hopkins University School of Medicine Division of Clinical Pharmacology conducted?

The Johns Hopkins University School of Medicine Division of Clinical Pharmacology has 1 clinical trials on record. Their work covers Cytochrome P450 CYP3A5 Enzyme Polymorphism, Healthy Subjects, Pharmacokinetics of Maraviroc.

Is The Johns Hopkins University School of Medicine Division of Clinical Pharmacology accredited by Crixeo Health?

The Johns Hopkins University School of Medicine Division of Clinical Pharmacology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Johns Hopkins University School of Medicine Division of Clinical Pharmacology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.